Similarly, in individuals with acute myocardial infarction (AMI), decreased serum adropin levels were linked to the presence of AMI in Coronary Artery Disease (CAD) patients, with adropin serving as an independent predictor for AMI [37], a possible role of adropin in CAD prevention [38], and the presence of good coronary collateral circulation [39]. This evidence concerns the gene ENHO and coronary artery disorder.